In Brief This Week: Almac Diagnostics; Leica, Aperio; GenScript; University of Nebraska | GenomeWeb

NEW YORK (GenomeWeb News) – Almac Diagnostics said this week that it has launched a next-generation sequencing service to its portfolio, which also includes microarray, qPCR, and immunohistochemical offerings. Northern Ireland-based Almac said that the new NGS service will initially use the Illumina MiSeq platform.


Leica Biosystems has entered into a definitive agreement to acquire Aperio, expanding its digital pathology business. Terms of the acquisition were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.